Meningitis B Vaccine to Be Used for Gonorrhea in England
In August 2025, England will become the first country to offer a vaccine for gonorrhea after cases exceed 85,000 in 2023—the highest gonorrhea levels since recordkeeping began in 1918. The program, offered through the United Kingdom’s National Health Service (NHS), will repurpose the meningitis B vaccine, routinely given to infants, in an attempt to reduce […]
Pfizer Ends Development of Weight-Loss Pill After Liver Injury in Trial Participant
Pfizer, Inc. announced that it is discontinuing development of its experimental daily weight loss pill after a trial participant suffered a liver injury potentially linked to the drug. The company confirmed that the oral GLP-1 drug, danuglipron (PF-06882961), is no longer in development following the incident.1 Pfizer has been studying danuglipron since 2022.2 A Pfizer […]
Moderna Continues mRNA Norovirus “Vaccine” Trials Following Guillain-Barré Case
A first-ever norovirus “vaccine”—another experimental biological product produced by Moderna, Inc., using novel mRNA technology—may be on the horizon even though last month the U.S. Food and Drug Administration (FDA) paused Moderna’s late-stage clinical trial following a report of Guillain-Barré syndrome (GBS), a rare neurological side effect that has also surfaced in its RSV vaccine […]
Nurse’s Death in U.K. Linked to Weight Loss Drug Mounjaro
A 58-year-old nurse’s death has been linked to the popular weight loss drug tirzepatide, sold under the brand name Mounjaro. While her certificate of death lists “multiple organ failure, septic shock, and pancreatitis” as the immediate cause of her passing, “the use of prescribed tirzepatide” is listed as a contributing factor. Susan McGowan had only […]
More Serious Side Effects from Ozempic and Wegovy Weight Loss Drugs
Another woman is suing Ozempic and Wegovy drugmaker Novo Nordisk, claiming that their popular GLP-1 (semaglutide) weight loss drugs led to a near-fatal emergency surgery and a lifelong ileostomy bag attached to her abdomen. Juanita Gantt was prescribed Ozempic and Wegovy by her doctor due to her increased diabetes risk, as she weighed 242 pounds […]
Weight Loss Drugs Ozempic and Wegovy Linked to Vision Loss
Semaglutide, the active ingredient in popular weight loss drugs sold under brand names like Ozempic and Wegovy, has been linked to a condition that causes vision loss, according to a new study published on July 3, 2024 in JAMA Ophthalmology. In the study, patients who were prescribed semaglutide were more likely to develop non-arteritic anterior […]